Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
Intact Genomics has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Intact Genomics's investors include National Institutes of Health, National Institute of Allergy and Infectious Diseases, Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship.
Intact Genomics is headquartered in Creve Coeur, United States.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
Intact Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intact Genomics — Funding & Investors." VCBacked, July 1, 2022, https://www.vcbacked.co/company/intact-genomics. Accessed July 20, 2026.
VCBacked. (2022). Intact Genomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/intact-genomics
{{cite web |title=Intact Genomics — Funding & Investors |url=https://www.vcbacked.co/company/intact-genomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated